Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
Conditions
- Central Nervous System Metastases
- Leptomeningeal Metastases
- Recurrent Breast Cancer
- Stage IV Breast Cancer
- Tumors Metastatic to Brain
Interventions
- DRUG: methotrexate
- DRUG: liposomal cytarabine
- OTHER: quality-of-life assessment
- OTHER: laboratory biomarker analysis
Sponsor
University of Washington
Collaborators